News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cyclogenix Enters Research Collaboration with Wyeth Pharmaceuticals (New Jersey) (WYE) and Queensland’s IMBcom


2/26/2009 11:44:54 AM

ABERDEEN, Scotland--(BUSINESS WIRE)--Cyclogenix Ltd today announced that it has entered into license and research agreements with Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE) and IMBcom, The University of Queensland’s (UQ) company for commercializing technology from the Institute for Molecular Bioscience (IMB).

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES